R&D

Pipeline Schedule

New Drug Pipeline Schedule

신약 파이프라인 개발 스케줄
Pipeline Target Preclinical Research Preclinical Development Phase 1/2
Cancer
Vaccine		 TB-CV-01 Personalized
Neoantigen
TB-CV-02 Shared
Neoantigen
Targeted
Thearpy		 TB-ADC-01 MUC13
TB-ADC-02 CEACAM5
TB-SM-01 MAPK3
Solid Tumor
2Q 2023 Trial Initiated
Solid Tumor
1Q 2024 Trial Initiated
Rectal, Colorectal
2025 Trial Initiated
Rectal,Colorectal
Rectal,Colorectal
Close